EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 2
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Australasia

Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye

Melbourne, Australia, November 19, 2018 / B3C newswire / -- Bionic Vision Technologies Pty Ltd (BVT) today announced medical researchers had successfully restored a s...
22 November 2018 Australasia | news
Continue Reading →
Australasia

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provider of...
19 November 2018 Australasia | Europe | news | North America | Regional News | Uncategorized
Continue Reading →
news

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. Cancer continues to be one of the top causes of death in the Uni...
15 November 2018 news | North America
Continue Reading →
Asia Pacific

EXUMA Biotech acquires strategic CAR-T assets

EXUMA Biotech integrates BioAtla's conditionally active biologic (CAB) protein therapeutic technology with F1 Oncology's proprietary CAR-T technologies to develop and...
15 November 2018 Asia Pacific | news
Continue Reading →
Europe

Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics

NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today an...
15 November 2018 Europe | news
Continue Reading →
Europe

Ionis, Akcea succeed in heart drug trial, setting up Novartis decision

Akcea Therapeutics and Ionis Pharmaceuticals rolled out successful Phase 2 study results Wednesday showing their drug candidate lowered Lp(a), short for lipoprotein(a...
15 November 2018 Europe | news | North America
Continue Reading →
Europe

‘Super’-responder analysis gives more power to Viking’s fatty liver drug

Researchers Monday presented more complete results from Viking Therapeutics' 12-week Phase 2 study of VK2809 at The Liver Meeting 2018, after previously announcing in...
15 November 2018 Europe | news | North America
Continue Reading →
news

Sobi snags rights to AstraZeneca drugs in another immunology play

Swedish pharma Sobi has inked a $1.5 billion cash and equity deal to secure rights to two AstraZeneca drugs that it believes will strengthen its position both in the ...
15 November 2018 news | North America
Continue Reading →
news

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturi...
15 November 2018 news | North America
Continue Reading →
news

Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compou...
8 November 2018 news | North America | Regional News
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte